SELECTIVE PROGESTERONE MODULATORS IN THE TREATMENT OF UTERINE BLEEDING
Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic coagulation disorders such as thrombopenia, coagulation factor deficiency or anti-coagulant therapy. Treatment will last fro...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
03.02.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic coagulation disorders such as thrombopenia, coagulation factor deficiency or anti-coagulant therapy. Treatment will last from 1 day to 180 days. |
---|---|
Bibliography: | Application Number: EP20080737471 |